TABLE 1.
Strain | Penicillins |
Cephalosporins |
Carbapenems |
Fluoroquinolones |
Aminoglycosides |
Tetracyclines |
Miscellaneous |
|||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMP |
SAM |
TZP |
CFZ |
FEP |
FOX |
CAZ |
CRO |
IMP |
MEM |
CIP |
LVX |
AMK |
GEN |
TOB |
TGC |
DOX |
CST |
SXT |
Ga-PPIX |
|||||||||||||||||||||
MICb,d | CIc | MICd | CI | MICd | CI | MICd | CI | MICe | CI | MICd | CI | MICe | CI | MICd | CI | MICf | CI | MICe | CI | MICe | CI | MICe | CI | MICf | CI | MICe | CI | MICe | CI | MICe | CI | MICh | CI | MICe | CI | MICe | CI | MICi | CI | |
ATCC 19606T | ≥32 | R | ≤2 | S | ≤4 | S | ≥64 | R | 24 | *g | ≥64 | R | 12 | * | 16 | I | ≤1 | S | 1.5 | S | 0.8 | S | 0.5 | S | 16 | S | 12 | R | 3 | S | 2 | * | 27 | S | 0.13 | S | >640 | R | 15 | * |
ATCC 17978 | ≥32 | R | ≤2 | S | ≤4 | S | ≥64 | R | 3 | S | ≥64 | R | 6 | S | 16 | I | 1 | S | 0.8 | S | 0.3 | S | 0.2 | S | ≤4 | S | 1.5 | S | 0.5 | S | 0.38 | * | 26 | S | 0.38 | S | >640 | R | 17 | * |
LUH07672 | ≥32 | R | ≤2 | S | ≤4 | S | ≥64 | R | 32 | R | ≥64 | R | >256 | R | ≥64 | R | ≤1 | S | 1.5 | S | >32 | R | 24 | R | >32 | R | >256 | R | 64 | R | 6 | * | 12 | I | 0.13 | S | >640 | R | 18 | * |
LUH08809 | ≥32 | R | 4 | S | ≥128 | R | ≥64 | R | 96 | R | ≥64 | R | 192 | R | ≥64 | R | ≤1 | S | 8 | I | >32 | R | >32 | R | >32 | R | >256 | R | >256 | R | 8 | * | 12 | I | 0.13 | S | >640 | R | 20 | * |
LUH05875 | ≥32 | R | 4 | S | ≥128 | R | ≥64 | R | >256 | R | ≥64 | R | 64 | R | ≥64 | R | ≤1 | S | 8 | I | >32 | R | >32 | R | >32 | R | >256 | R | 96 | R | 12 | * | 14 | S | 0.13 | S | >640 | R | 19 | * |
LUH13000 | ≥32 | R | 4 | S | ≥128 | R | ≥64 | R | 16 | I | ≥64 | R | ≥256 | R | ≥64 | R | 2 | S | 1 | S | >32 | R | >32 | R | >32 | R | >256 | R | 96 | R | 4 | * | 6 | R | 0.3 | S | >640 | R | 20 | * |
RUH00134 | ≥32 | R | ≥32 | R | 8 | S | ≥64 | R | 12 | I | ≥64 | R | 6 | S | 16 | I | ≤1 | S | 0.8 | S | 0.4 | S | 0.3 | S | 8 | S | ≥256 | R | 1.5 | S | 3 | * | 6 | R | 0.3 | S | ≥32 | R | 20 | * |
RUH00875 | ≥32 | R | ≥32 | R | 16 | S | ≥64 | R | 24 | I | ≥64 | R | 16 | I | 16 | I | ≤1 | S | 2 | S | 0.8 | S | 0.4 | S | 16 | S | >256 | R | >256 | R | 3 | * | 10 | I | 0.19 | S | >640 | R | 19 | * |
AYE | ≥32 | R | 8 | S | >128 | R | ≥64 | R | >256 | R | ≥64 | R | >256 | R | ≥64 | R | ≤1 | S | 2 | S | >32 | R | >32 | R | >32 | R | >256 | R | 48 | R | 3 | * | 15 | S | 0.38 | S | >640 | R | 14 | * |
SDF | ND | - | ND | - | ND | - | ND | - | 2 | S | ND | - | 4 | S | ND | - | ≤1 | S | 1 | S | 0.3 | S | 0.3 | S | <4 | S | 0.5 | S | 0.2 | S | 0.5 | * | 26 | S | 0.09 | S | 5 | S | 11 | * |
A118 | 16 | R | ≤2 | S | 8 | S | ≥64 | R | 3 | S | 4 | S | 6 | S | 16 | I | ≤1 | S | 0.8 | S | 0.2 | S | 0.1 | S | ≤4 | S | 1.5 | S | 0.8 | S | 0.38 | * | 27 | S | 0.13 | S | 0.8 | S | 18 | * |
ACICU | ≥32 | R | ≥32 | R | ≥128 | R | ≥64 | R | ≥256 | R | ≥64 | R | ≥256 | R | ≥64 | R | >8 | R | ≥32 | R | ≥32 | R | ≥32 | R | ≥32 | R | 16 | R | 16 | R | 4 | * | 15 | S | 0.13 | S | ≥32 | R | 18 | * |
Antibiotic abbreviations: AMK, amikacin; AMP, ampicillin; CAZ, ceftazidime; CFZ, cefazolin; CIP, ciprofloxacin; COX, ceftriaxone; CST, colistin; FEP, cefepime; FOX, cefoxitin; Ga-PPIX, gallium protoporphyrin IX; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM, meropenem; SAM, ampicillin-sulbactam; SXT, trimethoprim-sulfamethoxazole; TGC, tigecycline; TOB, tobramycin; TZP, piperacillin-tazobactam.
The MIC values are shown in micrograms per milliliter.
The categorical interpretations (CIs) are as follows: R, resistant; S, susceptible; I, intermediate; ND, not determined. Asterisks indicate the absence of interpretive standards.
MIC determined by Vitek-2 AST-GN73 card.
MIC determined by Etest.
MIC determined by BD Phoenix NMIC/ID-130 panel.
*, no interpretive standards available.
Susceptibility determined by Kirby-Bauer disk diffusion.
MIC determined by microdilution.